Babson

Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners

Retrieved on: 
Thursday, March 21, 2024
Supermarket, Health Technology, Pharmaceutical, Oncology, Teens, Medical Devices, Parenting, Infectious Diseases, Retail, Genetics, Fitness & Nutrition, Cardiology, Health, Seniors, Practice Management, Men, General Health, Family, Consumer, Diabetes, Other Retail, Other Health, Biometrics, Diagnosis, Temperature, Patient, Pharmacy, Pharmacist, Prescription, Babson, Insurance, Centrifugation, Texas Pharmacy Association, Collection, Blood, FDA

Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.

Key Points: 
  • Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.
  • BetterWay brings blood testing into the 21st century, making it less invasive, more convenient, and accessible for consumers.
  • “Blood testing hasn’t changed much in over 70 years,” said David Stein, Babson’s chief executive officer.
  • Without the need for a phlebotomist, Babson can bring medically accurate blood testing to new, more convenient settings such as community pharmacies.

Babson Diagnostics Recognized for Achieving Highest Standards of Quality and Patient Safety for Laboratory Medicine

Retrieved on: 
Wednesday, January 24, 2024
Other Health, Health, Science, Research, Health Technology, Patient, Diagnosis, Accreditation, Federation, Pharmacy, CAP, College, Babson, Blood

Babson will analyze the microsamples at its clinical lab, which opened last year inside its new corporate headquarters.

Key Points: 
  • Babson will analyze the microsamples at its clinical lab, which opened last year inside its new corporate headquarters.
  • CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
  • Babson’s compliance means the company is meeting the highest standards of quality and patient safety in its laboratory practices.
  • “Achieving accreditation is another step in our plan to show that BetterWay meets high scientific standards and produces quality diagnostic results that patients and clinicians can rely on.”

Babson Diagnostics’ BetterWay™ Blood Testing Service Achieves Critical Milestone Ahead of Commercialization

Retrieved on: 
Thursday, December 7, 2023
Biotechnology, Technology, FDA, Other Health, Health, General Health, Health Technology, Other Science, Other Technology, Medical Devices, Science, IRB, Food, CPT, Multimedia, Blood, Ecosystem, Centrifugation, Partnership, Pharmacy, Medical device, Hospital, Babson

View the full release here: https://www.businesswire.com/news/home/20231207903396/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231207903396/en/
    BetterWay™ Blood Testing, the name of its new diagnostic blood testing service that is designed around the most important element of testing – the customer.
  • (Graphic: Business Wire)
    BetterWay will reimagine the entire blood testing process, using only a pea-sized amount of blood collected from a fingertip and delivering results equivalent to traditional blood testing methods.
  • The BetterWay service will enable blood testing by non-phlebotomists in convenient locations without sacrificing quality, accuracy, or the types of tests that are possible.
  • “BetterWay is the blood testing service that consumers and health care professionals have been waiting for,” said David Stein, chief executive officer of Babson Diagnostics.

BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

Retrieved on: 
Thursday, December 7, 2023
Hypertension, Health equity, NYSE, BDX, Patient, FDA, Hematocrit, Health, Blood, Diagnosis, Partnership, Life, Pharmacy, Medical device, Pharmaceutical industry, Babson

FRANKLIN LAKES, N.J., Dec. 7, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.

Key Points: 
  • It is less invasive than traditional venous blood collection methods and more convenient for the patient by expanding access to blood collection to new locations, including retail pharmacies.
  • The 510(k) clearances include low-volume blood collection for a lipid panel, selected chemistry tests, and hemoglobin and hematocrit (H&H) testing.
  • BD plans to expand blood tests enabled by BD MiniDraw™ Collection System in the future.
  • We believe the BD MiniDraw™ Collection System is potentially a game-changing innovation that combines convenience and better patient experience with lab-quality results."

Babson College Commencement Ceremonies Celebrate the Class of 2023

Retrieved on: 
Monday, May 15, 2023
HarbourVest Partners, Finance Division, Reshma Kewalramani, Learning, Operation, Life, Joint Staff Information Management Division (United States), Electronics, Speech, PwC, Class, Babson College, Sam Fox School of Design & Visual Arts, Babson, Associate, Assistant, Visual arts, Human, Love, Sorenson, Child, Vertex Pharmaceuticals, 104th Wisconsin Legislature, Observation, Empathy, Faculty, Humanities, Information management, Circle, Nursing, Management

WELLESLEY, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Babson College celebrated the achievements of the Class of 2023 during its 104th undergraduate and 71st graduate commencement ceremonies held on Saturday, May 13.

Key Points: 
  • WELLESLEY, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Babson College celebrated the achievements of the Class of 2023 during its 104th undergraduate and 71st graduate commencement ceremonies held on Saturday, May 13.
  • And, so my simple message for the Class for 2023, I want you to lead with love,” said Ryan.
  • Migliozzi has received this honor twice in the past three years, the previous one given by the Class of 2021.
  • This award is given to a graduate professor nominated by a graduating student and voted upon by the graduating class.

Babson and Uwill Announce Partnership to Support Student Mental Health

Retrieved on: 
Thursday, May 11, 2023
Partnership, College, Education, Senior counsel, Babson College, Babson, Student, UC, LICSW, Risk, NASPA, Outline of counseling, Psychological Services, Trauma, Mental health, Counselor, Safety, University of California, Santa Barbara, Nursing

WELLESLEY, Mass., May 11, 2023 /PRNewswire/ -- Today, Babson College and Uwill, the leading teletherapy solution for colleges and students, announced a partnership to complement the college's existing counseling capabilities, and provide students additional mental health resources. As the mental health crisis continues to grow around higher education, Babson adds Uwill's proprietary technology to facilitate immediate appointments with licensed mental health counselors based on student needs. In addition, it directly connects students in crisis with licensed counselors trained in trauma to assess student risk, deescalate situations, and offer as-needed response.

Key Points: 
  • Babson College expands mental health options for students, adding teletherapy, a crisis connection, and wellness programming
    WELLESLEY, Mass., May 11, 2023 /PRNewswire/ -- Today, Babson College and Uwill, the leading teletherapy solution for colleges and students, announced a partnership to complement the college's existing counseling capabilities, and provide students additional mental health resources.
  • As the mental health crisis continues to grow around higher education, Babson adds Uwill's proprietary technology to facilitate immediate appointments with licensed mental health counselors based on student needs.
  • Babson adds this teletherapy option at a time where recent national survey data from Uwill and NASPA - Student Affairs Administrators in Higher Education shows a continued decline in student mental health.
  • 72% of student affairs and counseling leadership said the overall trajectory of campus mental health worsened during the past year.

Babson MBA Ranks # 1 in Entrepreneurship by the U.S. News & World Report for 30th Consecutive Time

Retrieved on: 
Tuesday, April 25, 2023
Social responsibility, Entrepreneurship, Employment, U.S. News & World Report, Curriculum, Education minister, Entrepreneurial leadership, Belonging, Babson College, Innovation, DEIB, MBA, Orientation, Doctor of Philosophy, Student, ET, Faculty, Environment, News, Dean (education), Management, Nursing, Babson

Wellesley, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- U.S News and World Report has ranked Babson’s MBA program # 1 in entrepreneurship for the 30th consecutive year in its 2023-2024 list of Best Graduate Schools.

Key Points: 
  • Wellesley, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- U.S News and World Report has ranked Babson’s MBA program # 1 in entrepreneurship for the 30th consecutive year in its 2023-2024 list of Best Graduate Schools.
  • “This is a moment of immense pride and celebration for the Babson community,” said Stephen Spinelli Jr. MBA’92, PhD, President of Babson College.
  • “The world needs entrepreneurial leaders in all fields to solve big and small problems.
  • From startups to rapidly evolving larger businesses and even municipalities, Babson graduates are creating social and economic value.”
    The world awaits Babson’s entrepreneurial leaders with open arms.

Babson Diagnostics Welcomes New Clinical Advisor, Andrew Carroll, M.D.

Retrieved on: 
Monday, April 10, 2023
Technology, Biotechnology, Alternative Medicine, Health, Other Health, Pharmaceutical, Other Science, Other Technology, Practice Management, Research, Medical Devices, General Health, Health Technology, Science, University, Diagnosis, Carroll, American Academy, Human, Multimedia, University of Arizona College of Medicine – Tucson, Babson, Patient, Collection, Physician, Blood, American Academy of Family Physicians, Pharmaceutical industry, Medical device

Andrew Carroll, M.D., a family physician and clinical assistant professor at the University of Arizona College of Medicine, will provide advice and counsel about clinical best practices and review validation data and reports.

Key Points: 
  • Andrew Carroll, M.D., a family physician and clinical assistant professor at the University of Arizona College of Medicine, will provide advice and counsel about clinical best practices and review validation data and reports.
  • Dr. Carroll will join Babson at industry events, trade shows, and clinical meetings.
  • He will also assist in assembling a clinical advisory board to support the company in embedding clinical best practices.
  • “I love collaborating with innovative companies like Babson who are focused on making health easier for all.”

Babson Diagnostics and ClosedLoop Team Selected as 1st Place Winner of ‘Help with Hemolysis’ Data Analytics Challenge

Retrieved on: 
Tuesday, March 28, 2023
Other Health, Retail, Other Science, Artificial Intelligence, Medical Devices, Professional Services, Science, Technology, Clinical Trials, Managed Care, Medical Supplies, Other Communications, Data Analytics, Public Relations, Investor Relations, Marketing, Other Retail, Health, Communications, Hemolysis, AACC, Diagnosis, Intelligence, Washington University in St. Louis, Collection, Pathology, Machine learning, Informatics, Medical device, Babson

Babson Diagnostics, a science-first healthcare technology company, and ClosedLoop, the leading healthcare data science platform, today announced their team was selected as the first-place winner of the ‘ Help with Hemolysis ’ Data Analytics Challenge.

Key Points: 
  • Babson Diagnostics, a science-first healthcare technology company, and ClosedLoop, the leading healthcare data science platform, today announced their team was selected as the first-place winner of the ‘ Help with Hemolysis ’ Data Analytics Challenge.
  • Babson Diagnostics and ClosedLoop have worked together closely since 2021, when the two companies collaborated to develop artificial intelligence solutions, which help detect and prevent sample quality errors that can occur when working with capillary blood samples.
  • So it was a natural fit for the companies to team up to tackle the ‘Help with Hemolysis’ challenge.
  • “We felt uniquely positioned to solve this challenge with our partners at Babson Diagnostics.

Babson Diagnostics Unveils Brand Identity for Next-Generation Blood Testing

Retrieved on: 
Thursday, February 2, 2023
Retail, Blogging, Other Communications, Other Health, Technology, Public Relations, Investor Relations, Marketing, Advertising, Communications, Medical Devices, Other Retail, Other Technology, Science, Other Science, Health, Patient, Research, Blood, Multimedia, Collection, Pharmacy, Human, Diagnosis, Centrifugation, Medical device, Pharmaceutical industry, Babson

Babson Diagnostics, a science-first, health care technology company, today announced BetterWay™ Blood Testing, the name of its new diagnostic blood testing service that is designed around the most important element of testing – the customer.

Key Points: 
  • Babson Diagnostics, a science-first, health care technology company, today announced BetterWay™ Blood Testing, the name of its new diagnostic blood testing service that is designed around the most important element of testing – the customer.
  • View the full release here: https://www.businesswire.com/news/home/20230202005272/en/
    BetterWay™ Blood Testing, the name of its new diagnostic blood testing service that is designed around the most important element of testing – the customer.
  • “The new brand amplifies our mission of making health easier for all,” said David Stein, chief executive officer of Babson Diagnostics.
  • BetterWay Blood Testing brings these innovations together to enable blood testing that requires only one-tenth the sample volume of venipuncture methods without sacrificing quality, accuracy, or the number of tests that are possible.